TY - JOUR
T1 - Variation of lipids and lipoproteins in premenopausal women compared with men and postmenopausal women
AU - Reed, R. G.
AU - Kris-Etherton, P.
AU - Stewart, P. W.
AU - Pearson, T. A.
N1 - Funding Information:
From the M.I. Bassett Research Institute, Bassett Healthcare, Cooperstown, NY; Nutrition Department, Pennsylvania State University, University Park, PA; and Department of Biostatistics, University of North Carolina, Chapel Hill, NC. Submitted December 2, 1997; accepted March 20, 2000. Supported by the National Institutes of Health (National Heart, Lung, and Blood Institute Grants No. HL49644, HL49648, HL49649, HL49651, and HL49659). Address reprint requests to Roberta G. Reed, PhD, M.I. Bassett Research Institute, Bassett Healthcare, One Atwell Road, Cooperstown, NY 13326. Copyright r 2000 by W.B. Saunders Company 0026-0495/00/4909-0005$10.00/0 doi:10.1053/meta.2000.8603
PY - 2000
Y1 - 2000
N2 - Numerous studies have reported cyclic fluctuations in lipids and lipoproteins as a function of the phase of the menstrual cycle. However, the reported patterns are quite variable and have led to an unclear picture of the influence of the menstrual cycle on the variability of lipids, and hence of the role of the menstrual cycle phase in the interpretation of serum lipids for premenopausal women. As part of the DELTA Study (Dietary Effects on Lipoproteins and Thrombogenic Activity), we evaluated the cyclic variation of circulating lipids and lipoproteins in 39 premenopausal women and compared intraindividual variances in these women, 18 postmenopausal women, and 46 men under conditions of tight dietary control. Cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, triglyceride, apolipoproteins A-1 (apo A-1) and B-100 (apo B-100), and lipoprotein (a) [Lp(a)] all demonstrated cycling in the premenopausal women. However, the observed cycling accounts for only a small fraction of the total biologic variability of lipids in premenopausal women. The magnitude of total intraindividual variability based on coefficient of variation (CV) for these lipids in premenopausal women (CV, 4% to 8.1%) was similar to that found for men (CV, 4.3% to 9.1%) and for postmenopausal women (CV, 3.7% to 6.7%). These results suggest that protocols for screening and monitoring of serum lipids in premenopausal women need not differ from those used for men or postmenopausal women. Copyright (C) 2000 by W.B. Saunders Company.
AB - Numerous studies have reported cyclic fluctuations in lipids and lipoproteins as a function of the phase of the menstrual cycle. However, the reported patterns are quite variable and have led to an unclear picture of the influence of the menstrual cycle on the variability of lipids, and hence of the role of the menstrual cycle phase in the interpretation of serum lipids for premenopausal women. As part of the DELTA Study (Dietary Effects on Lipoproteins and Thrombogenic Activity), we evaluated the cyclic variation of circulating lipids and lipoproteins in 39 premenopausal women and compared intraindividual variances in these women, 18 postmenopausal women, and 46 men under conditions of tight dietary control. Cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, triglyceride, apolipoproteins A-1 (apo A-1) and B-100 (apo B-100), and lipoprotein (a) [Lp(a)] all demonstrated cycling in the premenopausal women. However, the observed cycling accounts for only a small fraction of the total biologic variability of lipids in premenopausal women. The magnitude of total intraindividual variability based on coefficient of variation (CV) for these lipids in premenopausal women (CV, 4% to 8.1%) was similar to that found for men (CV, 4.3% to 9.1%) and for postmenopausal women (CV, 3.7% to 6.7%). These results suggest that protocols for screening and monitoring of serum lipids in premenopausal women need not differ from those used for men or postmenopausal women. Copyright (C) 2000 by W.B. Saunders Company.
UR - http://www.scopus.com/inward/record.url?scp=0033817124&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033817124&partnerID=8YFLogxK
U2 - 10.1053/meta.2000.8603
DO - 10.1053/meta.2000.8603
M3 - Article
C2 - 11016887
AN - SCOPUS:0033817124
SN - 0026-0495
VL - 49
SP - 1101
EP - 1105
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
IS - 9
ER -